The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes
TRANSFUSION AND APHERESIS SCIENCE, vol.59, no.5, 2020 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 59 Issue: 5
- Publication Date: 2020
- Doi Number: 10.1016/j.transci.2020.102845
- Journal Name: TRANSFUSION AND APHERESIS SCIENCE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, EMBASE, MEDLINE
- Inonu University Affiliated: Yes
Abstract
Purpose: Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to investigate both the impact of comorbidities and transfusion frequencies on the survival and quality of life of patients with myelodysplastic syndromes (MDS).